These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16977661)

  • 61. Thioredoxin-thioredoxin reductase--a system that has come of age.
    Williams CH
    Eur J Biochem; 2000 Oct; 267(20):6101. PubMed ID: 11012660
    [No Abstract]   [Full Text] [Related]  

  • 62. Protein electrophoretic mobility shift assay to monitor redox state of thioredoxin in cells.
    Bersani NA; Merwin JR; Lopez NI; Pearson GD; Merrill GF
    Methods Enzymol; 2002; 347():317-26. PubMed ID: 11898422
    [No Abstract]   [Full Text] [Related]  

  • 63. Ab initio and QM/MM study of electron addition on the disulfide bond in thioredoxin.
    Rickard GA; Bergès J; Houèe-Levin C; Rauk A
    J Phys Chem B; 2008 May; 112(18):5774-87. PubMed ID: 18447348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Communication between the nucleotide site and the main molecular hinge of 3-phosphoglycerate kinase.
    Szabó J; Varga A; Flachner B; Konarev PV; Svergun DI; Závodszky P; Vas M
    Biochemistry; 2008 Jul; 47(26):6735-44. PubMed ID: 18540639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mammalian thioredoxin reductases.
    Tamura T; Stadtman TC
    Methods Enzymol; 2002; 347():297-306. PubMed ID: 11898419
    [No Abstract]   [Full Text] [Related]  

  • 66. Acid-base catalysis in the mechanism of thioredoxin reductase from Drosophila melanogaster.
    Huang HH; Arscott LD; Ballou DP; Williams CH
    Biochemistry; 2008 Feb; 47(6):1721-31. PubMed ID: 18211101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A New Member of the Thioredoxin Reductase Family from Early Oxygenic Photosynthetic Organisms.
    Buey RM; Galindo-Trigo S; López-Maury L; Velázquez-Campoy A; Revuelta JL; Florencio FJ; de Pereda JM; Schürmann P; Buchanan BB; Balsera M
    Mol Plant; 2017 Jan; 10(1):212-215. PubMed ID: 27418374
    [No Abstract]   [Full Text] [Related]  

  • 68. Using chemical approaches to study selenoproteins-focus on thioredoxin reductases.
    Hondal RJ
    Biochim Biophys Acta; 2009 Nov; 1790(11):1501-12. PubMed ID: 19406205
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Crystal structure of the yeast cytoplasmic thioredoxin Trx2.
    Bao R; Chen Y; Tang YJ; Janin J; Zhou CZ
    Proteins; 2007 Jan; 66(1):246-9. PubMed ID: 17044062
    [No Abstract]   [Full Text] [Related]  

  • 70. Selenoprotein K form an intermolecular diselenide bond with unusually high redox potential.
    Liu J; Zhang Z; Rozovsky S
    FEBS Lett; 2014 Sep; 588(18):3311-21. PubMed ID: 25117454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Binary reducing equivalent pathways using NADPH-thioredoxin reductase and ferredoxin-thioredoxin reductase in the cyanobacterium Synechocystis sp. strain PCC 6803.
    Hishiya S; Hatakeyama W; Mizota Y; Hosoya-Matsuda N; Motohashi K; Ikeuchi M; Hisabori T
    Plant Cell Physiol; 2008 Jan; 49(1):11-8. PubMed ID: 18003670
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes.
    Lemarechal H; Anract P; Beaudeux JL; Bonnefont-Rousselot D; Ekindjian OG; Borderie D
    Free Radic Res; 2007 Jun; 41(6):688-98. PubMed ID: 17516242
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase.
    Rigobello MP; Vianello F; Folda A; Roman C; Scutari G; Bindoli A
    Biochem Biophys Res Commun; 2006 May; 343(3):873-8. PubMed ID: 16564501
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of protein targets of mammalian thioredoxin reductases.
    Turanov AA; Hatfield DL; Gladyshev VN
    Methods Enzymol; 2010; 474():245-54. PubMed ID: 20609914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. News and views on thioredoxin reductases.
    Gromer S; Schirmer RH; Becker K
    Redox Rep; 1999; 4(5):221-8. PubMed ID: 10731096
    [No Abstract]   [Full Text] [Related]  

  • 76. Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology.
    Yoo MH; Carlson BA; Tsuji P; Irons R; Gladyshev VN; Hatfield DL
    Methods Enzymol; 2010; 474():255-75. PubMed ID: 20609915
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterize direct protein interactions with enrichable, cleavable and latent bioreactive unnatural amino acids.
    Liu DD; Ding W; Cheng JT; Wei Q; Lin Y; Zhu TY; Tian J; Sun K; Zhang L; Lu P; Yang F; Liu C; Tang S; Yang B
    Nat Commun; 2024 Jun; 15(1):5221. PubMed ID: 38890329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expanding the repertoire of the eukaryotic selenoproteome.
    Stillwell RJ; Berry MJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16123-4. PubMed ID: 16263922
    [No Abstract]   [Full Text] [Related]  

  • 79. Selenoproteins - biochemistry and clinical relevance.
    Böck A; Flohé L; Köhrle J
    Biol Chem; 2007 Oct; 388(10):985-6. PubMed ID: 17937611
    [No Abstract]   [Full Text] [Related]  

  • 80. New mammalian selenium-containing protein V: the search for protein partners.
    Varlamova EG; Novoselov SV; Novoselov VI; Fesenko EE
    Dokl Biochem Biophys; 2011; 441():255-7. PubMed ID: 22218948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.